Published in J Neurosurg on July 01, 2000
"Syndrome of the sinking skin-flap" secondary to the ventriculoperitoneal shunt after craniectomy. J Korean Neurosurg Soc (2008) 1.01
Case report of MR perfusion imaging in sinking skin flap syndrome: growing evidence for hemodynamic impairment. BMC Neurol (2010) 0.96
Clinical analysis of epidural fluid collection as a complication after cranioplasty. J Korean Neurosurg Soc (2014) 0.92
Cranioplasty with autologous cryopreserved bone after decompressive craniectomy: complications and risk factors for developing surgical site infection. Acta Neurochir (Wien) (2014) 0.90
Response to "Quantifying the health impacts of ambient air pollutants: methodological errors must be avoided". Int J Public Health (2016) 0.90
The "Skull Flap" a new conceived device for decompressive craniectomy/cranioplasty: Feasibility study on cadaver specimen. J Neurosci Rural Pract (2013) 0.85
Neurological susceptibility to a skull defect. Surg Neurol Int (2014) 0.83
Cranioplasty with polymethylmethacrylate prostheses fabricated by hand using original bone flaps: Technical note and surgical outcomes. Surg Neurol Int (2013) 0.83
The impact of cranioplasty on cerebral blood flow and its correlation with clinical outcome in patients underwent decompressive craniectomy. Asian J Neurosurg (2016) 0.82
Cranioplasty prosthesis manufacturing based on reverse engineering technology. Med Sci Monit (2012) 0.82
An Improved One-Stage Operation of Cranioplasty and Ventriculoperitoneal Shunt in Patient with Hydrocephalus and Large Cranial Defect. Korean J Neurotrauma (2015) 0.81
Prefabricated patient-matched cranial implants for reconstruction of large skull defects. J Cent Nerv Syst Dis (2013) 0.80
Reconstruction of a large complex skull defect in a child: a case report and literature review. Childs Nerv Syst (2007) 0.80
Comprehensive cognitive and cerebral hemodynamic evaluation after cranioplasty. Neuropsychiatr Dis Treat (2014) 0.79
Temporal changes in CT perfusion values before and after cranioplasty in patients without symptoms related to external decompression: a pilot study. Neuroradiology (2014) 0.78
Microsurgical reconstruction of large, locally advanced cutaneous malignancy of the head and neck. Int J Surg Oncol (2011) 0.78
Factors influencing the outcome (GOS) in reconstructive cranioplasty. Neurosurg Rev (2015) 0.77
The "Skull Flap" a new conceived device for decompressive craniectomy experimental study on dogs to evaluate the safety and efficacy in reducing intracranial pressure and subsequent impact on brain perfusion. J Neurosci Rural Pract (2013) 0.75
Comparison of Complications Following Cranioplasty Using a Sterilized Autologous Bone Flap or Polymethyl Methacrylate. Korean J Neurotrauma (2017) 0.75
Paradoxical Herniation in the Postcraniectomy Syndrome: Report and Literature Update. J Neurol Surg Rep (2016) 0.75
Importance of Early Cranioplasty in Reversing the "Syndrome of the Trephine/Motor Trephine Syndrome/Sinking Skin Flap Syndrome". J Maxillofac Oral Surg (2014) 0.75
Sinking skin flap syndrome in glioblastoma. BMJ Case Rep (2014) 0.75
Effects of Early Cranioplasty on the Restoration of Cognitive and Functional Impairments. Ann Rehabil Med (2017) 0.75
Radiological signs of the syndrome of the trephined. Neuroradiology (2016) 0.75
Kinetics of interaction of nucleotides with nucleotide-free H-ras p21. Biochemistry (1990) 2.55
Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group. Mov Disord (2000) 2.10
Normal IPT and IBZM SPECT in drug-naive and levodopa-treated idiopathic restless legs syndrome. Neurology (2001) 1.83
EANM procedure guidelines for brain tumour imaging using labelled amino acid analogues. Eur J Nucl Med Mol Imaging (2006) 1.79
Transorbital keyhole approach to anterior communicating artery aneurysms. Neurosurgery (2001) 1.79
FTDP-17: an early-onset phenotype with parkinsonism and epileptic seizures caused by a novel mutation. Ann Neurol (1999) 1.75
Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography. Neurosci Lett (2000) 1.65
Influence of thyroid-stimulating hormone levels on uptake of FDG in recurrent and metastatic differentiated thyroid carcinoma. J Nucl Med (2000) 1.50
Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment. Eur J Nucl Med (2000) 1.48
Terson's syndrome in subarachnoid hemorrhage and severe brain injury accompanied by acutely raised intracranial pressure. J Neurosurg (1998) 1.46
Indium-111 pentetreotide in the diagnostic work-up of patients with bronchogenic carcinoma. Eur J Nucl Med (1994) 1.42
D2 receptor occupancy under recommended and high doses of olanzapine: an iodine-123-iodobenzamide SPECT study. J Psychopharmacol (2000) 1.39
Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder. Comparison with Parkinson's disease and controls. Brain (2000) 1.35
Crystallization and preliminary X-ray analysis of the human c-H-ras-oncogene product p21 complexed with GTP analogues. J Mol Biol (1989) 1.24
BRAF-KIAA1549 fusion transcripts are less frequent in pilocytic astrocytomas diagnosed in adults. Neuropathol Appl Neurobiol (2011) 1.15
O-(2-[18F]fluoroethyl)-L-tyrosine PET for monitoring the effects of convection-enhanced delivery of paclitaxel in patients with recurrent glioblastoma. Eur J Nucl Med Mol Imaging (2005) 1.14
Substrate and product structural requirements for binding of nucleotides to H-ras p21: the mechanism of discrimination between guanosine and adenosine nucleotides. Biochemistry (1995) 1.06
Mechanisms of 5-aminolevulinic acid uptake at the choroid plexus. J Neurochem (2000) 1.04
Importance of changes in gastric emptying for postprandial plasma glucose fluxes in healthy humans. Am J Physiol Endocrinol Metab (2007) 1.01
Retinal microvasculopathy and reduced cerebral blood flow in patients with acquired immunodeficiency syndrome. Am J Ophthalmol (1992) 1.00
18F-FDG PET studies in patients with extratemporal and temporal epilepsy: evaluation of an observer-independent analysis. J Nucl Med (1999) 0.99
The positive predictive value of O-(2-[18F]fluoroethyl)-L-tyrosine (FET) PET in the diagnosis of a glioma recurrence after multimodal treatment. J Neurooncol (2008) 0.99
Transport of 5-aminolevulinic acid between blood and brain. Brain Res (2003) 0.98
[Diagnosis and treatment of colorectal liver metastases - workflow]. Zentralbl Chir (2008) 0.98
The influence of cranioplasty on postural blood flow regulation, cerebrovascular reserve capacity, and cerebral glucose metabolism. Neurosurg Focus (2000) 0.98
European Association of Nuclear Medicine procedure guidelines for brain imaging using [(18)F]FDG. Eur J Nucl Med Mol Imaging (2002) 0.97
Radiofrequency ablation after selective internal radiation therapy with Yttrium90 microspheres in metastatic liver disease-Is it feasible? Eur J Radiol (2009) 0.97
HERG1 gene expression as a specific tumor marker in colorectal tissues. Eur J Surg Oncol (2009) 0.97
Primary aspergillosis of the sphenoid sinus with pituitary invasion - a rare differential diagnosis of sellar lesions. Acta Neurochir (Wien) (2006) 0.96
Amyloid fibrils derived from V-region together with C-region fragments from a lambda II-immunoglobulin light chain (HAR). Biol Chem Hoppe Seyler (1985) 0.96
ALA-induced porphyrin accumulation in medulloblastoma and its use for fluorescence-guided surgery. Cent Eur Neurosurg (2010) 0.96
European Association of Nuclear Medicine procedure guidelines for brain neurotransmission SPET using (123)I-labelled dopamine D(2) transporter ligands. Eur J Nucl Med Mol Imaging (2002) 0.95
Relationship between clinical features of Parkinson's disease and presynaptic dopamine transporter binding assessed with [123I]IPT and single-photon emission tomography. Eur J Nucl Med (1997) 0.95
FDG-PET and IBZM-SPECT suggest reduced thalamic activity but no dopaminergic dysfunction in chronic alcohol hallucinosis. J Neuropsychiatry Clin Neurosci (2000) 0.95
Topography of thalamic and parabrachial calcitonin gene-related peptide (CGRP) immunoreactive neurons projecting to subnuclei of the amygdala and extended amygdala. J Comp Neurol (2007) 0.94
Creatine supplementation in Parkinson disease: a placebo-controlled randomized pilot trial. Neurology (2006) 0.94
18F-FDG PET and 99mTc-sestamibi scintimammography for monitoring breast cancer response to neoadjuvant chemotherapy: a comparative study. Eur J Nucl Med (2001) 0.92
[German guidelines for brain tumour imaging by PET and SPECT using labelled amino acids]. Nuklearmedizin (2011) 0.92
Usefulness of 3-D reconstructed images of the human cerebral cortex for localization of subdural electrodes in epilepsy surgery. Epilepsy Res (2000) 0.92
PET and SPECT findings in alcohol hallucinosis: case report and super-brief review of the pathophysiology of this syndrome. World J Biol Psychiatry (2000) 0.91
Supratentorial meningeal melanocytoma mimicking a convexity meningioma. Acta Neurochir (Wien) (2006) 0.90
Strategy of measuring bradykinin and kallidin and their concentration in plasma and urine. Anal Biochem (1995) 0.90
Abnormalities of cerebral blood flow in the acute phase of bacterial meningitis in adults. J Neurol (1992) 0.89
123I-iodobenzamide-SPECT predicts dopaminergic responsiveness in patients with de novo parkinsonism. Neurology (1992) 0.89
Relation between ictal asystole and cardiac sympathetic dysfunction shown by MIBG-SPECT. Acta Neurol Scand (2009) 0.88
Bilateral primary adrenal non-Hodgkin's lymphoma - a case report and review of the literature. Eur J Med Res (2008) 0.88
Dopaminergic deficit in amyotrophic lateral sclerosis assessed with [I-123] IPT single photon emission computed tomography. J Neurol Neurosurg Psychiatry (1998) 0.88
Comparison of 123I-IBZM SPECT and 11C-raclopride PET findings in patients with parkinsonism. Nucl Med Commun (1994) 0.88
Transcallosal interforniceal-transforaminal approach for removing lesions occupying the third ventricular space: clinical and neuropsychological results. Neurosurgery (2000) 0.88
Signal changes on MRI and increases in reactive microgliosis, astrogliosis, and iron in the putamen of two patients with multiple system atrophy. J Neurol Neurosurg Psychiatry (1996) 0.88
Thalamic astrocytomas: surgical anatomy and results of a pilot series using maximum microsurgical removal. Acta Neurochir (Wien) (2000) 0.88
Reduced cerebral blood flow in early stages of human immunodeficiency virus infection. Arch Neurol (1990) 0.87
Optimization of automated quantification of 123I-IBZM uptake in the striatum applied to parkinsonism. J Nucl Med (2000) 0.87
[Two rare complications following implantation of total hip endoprostheses with a ceramic head]. Beitr Orthop Traumatol (1989) 0.87
Hypermetabolic pattern in frontal cortex and other brain regions in unmedicated schizophrenia patients. Results from a FDG-PET study. Eur Arch Psychiatry Clin Neurosci (2005) 0.87
The use of [18 F]fluorodeoxyglucose positron emission tomography to differentiate between synovitis, loosening and infection of hip and knee prostheses. Nucl Med Commun (2002) 0.87
Group experiments on the radioimmunological insulin determination. Horm Metab Res (1974) 0.86
Marked reduction of striatal dopamine D2 receptors as detected by 123IBZM-SPECT in a Wilson's disease patient with generalized dystonia. Mov Disord (1992) 0.86
HIV-induced chorea: evidence for basal ganglia dysregulation by SPECT. J Neurol (2005) 0.86
A biophysical explanation for Nd:YAG percutaneous laser disc decompression success. J Clin Laser Med Surg (2001) 0.85
MR measurement of regional relative cerebral blood volume in epilepsy. J Magn Reson Imaging (1999) 0.85
Behavioral effects and pattern of brain c-fos mRNA induced by 2,5-dihydro-2,4,5-trimethylthiazoline, a component of fox feces odor in GAD67-GFP knock-in C57BL/6 mice. Behav Brain Res (2009) 0.85
Perfusion MRI before and after acetazolamide administration for assessment of cerebrovascular reserve capacity in patients with symptomatic internal carotid artery (ICA) occlusion: comparison with 99mTc-ECD SPECT. Neuroradiology (2007) 0.85
Anatomic features of glioblastoma and their potential impact on survival. Acta Neurochir (Wien) (2014) 0.84
[Therapy response of liver tumors after selective internal radiation therapy]. Radiologe (2008) 0.84
Use of three-phase bone scans and SPET in the follow-up of patients with allogenic vascularized femur transplants. Nucl Med Commun (1999) 0.84
Blood-brain barrier glutamine transport during normoglycemic and hyperglycemic focal cerebral ischemia. J Cereb Blood Flow Metab (1999) 0.84
[Lymphoscintigraphy for non-invasive long term follow-up of functional outcome in patients with autologous lymph vessel transplantation]. Nuklearmedizin (1996) 0.84
Ictal ECD-SPECT differentiates between temporal and extratemporal epilepsy: confirmation by excellent postoperative seizure control. Nucl Med Commun (2001) 0.84
Lymphoscintigraphy in penile cancer: limited value of sentinel node biopsy in patients with clinically suspicious lymph nodes. World J Urol (2006) 0.83
Fibrin-fibronectin compounds in human ovarian tumor ascites and their possible relation to the tumor stroma. Cancer Res (1988) 0.83
Heat-shock protein 70-dependent dendritic cell activation by 5-aminolevulinic acid-mediated photodynamic treatment of human glioblastoma spheroids in vitro. Br J Cancer (2011) 0.82
Oedema formation in experimental photo-irradiation therapy of brain tumours using 5-ALA. Acta Neurochir (Wien) (2005) 0.82
Inducible nitric oxide synthase: a possible key factor in the pathogenesis of chronic vasospasm after experimental subarachnoid hemorrhage. J Neurosurg (1999) 0.82
Locoregional radioimmunotherapy in selected patients with malignant glioma: experiences, side effects and survival times. J Neurooncol (2003) 0.82
Two Wistar rat lines selectively bred for anxiety-related behavior show opposite reactions in elevated plus maze and fear-sensitized acoustic startle tests. Behav Genet (2004) 0.82
Alteration of the striatal dopaminergic system in human narcolepsy. Neurology (2003) 0.82
Striatal D2-dopamine receptor occupancy during treatment with typical and atypical neuroleptics. Biol Psychiatry (1994) 0.82
Measurement of transit disorders in different gastrointestinal segments of patients with diabetes mellitus in relation to duration and severity of the disease by use of the metal-detector test. Z Gastroenterol (1995) 0.81
123I-iodobenzamide-SPECT in 83 patients with de novo parkinsonism. Neurology (1993) 0.81
Estradiol stimulates vascular endothelial growth factor and interleukin-6 in human lactotroph and lactosomatotroph pituitary adenomas. Exp Clin Endocrinol Diabetes (2004) 0.81
Surgery of the thoracic aorta using deep hypothermic total circulatory arrest. Are there neurological consequences other than frank cerebral defects? Eur J Cardiothorac Surg (1997) 0.81
Fine structure of rat septohippocampal neurons: I. Identification of septohippocampal projection neurons by retrograde tracing combined with electron microscopic immunocytochemistry and intracellular staining. J Comp Neurol (1992) 0.81
Management of patients with low-grade gliomas - a survey among German neurosurgical departments. Cent Eur Neurosurg (2011) 0.81
Technetium-99m-sestamibi scintimammography for the detection of breast carcinoma: comparison between planar and SPECT imaging. J Nucl Med (1998) 0.81
D2-dopamine receptor occupancy differs between patients with and without extrapyramidal side effects. Acta Psychiatr Scand (1994) 0.81
Pharmacokinetics and tissue distribution of idarubicin and its active metabolite idarubicinol in the rabbit. Cancer Chemother Pharmacol (1997) 0.81
Striatal dopamine transporter binding assessed by [I-123]IPT and single photon emission computed tomography in patients with early Parkinson's disease: implications for a preclinical diagnosis. Arch Neurol (2000) 0.80